NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 195 filers reported holding NEVRO CORP in Q1 2017. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $106,000 | -37.6% | 913 | -10.8% | 0.01% | -30.0% |
| Q2 2021 | $170,000 | -62.2% | 1,023 | -87.1% | 0.02% | -77.5% |
| Q3 2018 | $450,000 | -39.5% | 7,900 | -15.2% | 0.09% | -40.3% |
| Q2 2018 | $744,000 | -6.1% | 9,314 | +1.9% | 0.15% | -10.2% |
| Q1 2018 | $792,000 | +11.9% | 9,137 | -11.0% | 0.17% | +19.4% |
| Q4 2017 | $708,000 | -34.0% | 10,265 | -13.0% | 0.14% | -28.4% |
| Q3 2017 | $1,072,000 | +49.9% | 11,803 | +22.9% | 0.19% | +50.4% |
| Q2 2017 | $715,000 | -45.7% | 9,600 | -31.7% | 0.13% | -35.5% |
| Q1 2017 | $1,317,000 | +77.3% | 14,049 | +37.3% | 0.20% | +73.9% |
| Q4 2016 | $743,000 | -47.3% | 10,229 | -24.2% | 0.12% | -38.8% |
| Q3 2016 | $1,409,000 | +43.2% | 13,500 | +1.2% | 0.19% | +52.8% |
| Q2 2016 | $984,000 | +20.6% | 13,335 | -8.1% | 0.12% | +24.2% |
| Q1 2016 | $816,000 | -18.9% | 14,514 | -2.6% | 0.10% | -3.9% |
| Q4 2015 | $1,006,000 | +93.5% | 14,904 | +33.0% | 0.10% | +98.1% |
| Q3 2015 | $520,000 | -56.3% | 11,204 | -49.4% | 0.05% | -49.0% |
| Q2 2015 | $1,191,000 | +436.5% | 22,159 | +379.4% | 0.10% | +466.7% |
| Q1 2015 | $222,000 | – | 4,622 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
| Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
| Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
| Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
| Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
| Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
| Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
| ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
| PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |